CA1338468C - Separateurs pour composants du sang - Google Patents

Separateurs pour composants du sang

Info

Publication number: CA1338468C
Authority: CA; Canada
Prior art keywords: chamber; tube; blood; sample; passage
Prior art date: 1989-05-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA 601973

Other languages

English (en)

Inventor

William John Godolphin

James Allan Mcewen

Rainer Mattias Bohl

Mark Nicholas Dance

Martin Lewis Furse

John Calvin Osborne

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

DuPont Canada Inc

Original Assignee

DuPont Canada Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-05-02

Filing date

1989-06-07

Publication date

1996-07-23

1989-05-02 Priority claimed from US07/346,063 external-priority patent/US5030341A/en

1989-06-07 Application filed by DuPont Canada Inc filed Critical DuPont Canada Inc

1996-07-23 Application granted granted Critical

1996-07-23 Publication of CA1338468C publication Critical patent/CA1338468C/fr

2013-07-23 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

210000004369 blood Anatomy 0.000 title abstract description 130
239000008280 blood Substances 0.000 title abstract description 130
239000012530 fluid Substances 0.000 claims abstract description 45
239000007788 liquid Substances 0.000 claims abstract description 17
238000000638 solvent extraction Methods 0.000 claims abstract description 15
238000000926 separation method Methods 0.000 claims description 88
238000004891 communication Methods 0.000 claims description 10
239000012780 transparent material Substances 0.000 claims description 2
239000000523 sample Substances 0.000 description 134
210000002966 serum Anatomy 0.000 description 39
230000004888 barrier function Effects 0.000 description 26
230000001413 cellular effect Effects 0.000 description 24
239000000306 component Substances 0.000 description 24
210000002381 plasma Anatomy 0.000 description 20
238000000034 method Methods 0.000 description 18
230000003287 optical effect Effects 0.000 description 15
239000000463 material Substances 0.000 description 13
238000007789 sealing Methods 0.000 description 12
238000004458 analytical method Methods 0.000 description 10
238000005119 centrifugation Methods 0.000 description 10
239000007787 solid Substances 0.000 description 6
239000000126 substance Substances 0.000 description 6
102000009123 Fibrin Human genes 0.000 description 5
108010073385 Fibrin Proteins 0.000 description 5
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 5
239000003146 anticoagulant agent Substances 0.000 description 5
229940127219 anticoagulant drug Drugs 0.000 description 5
238000010276 construction Methods 0.000 description 5
229950003499 fibrin Drugs 0.000 description 5
231100001261 hazardous Toxicity 0.000 description 5
230000008569 process Effects 0.000 description 5
238000012546 transfer Methods 0.000 description 5
210000000601 blood cell Anatomy 0.000 description 4
238000001914 filtration Methods 0.000 description 4
238000002955 isolation Methods 0.000 description 4
239000004033 plastic Substances 0.000 description 4
229920003023 plastic Polymers 0.000 description 4
238000012545 processing Methods 0.000 description 4
230000008901 benefit Effects 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
230000008859 change Effects 0.000 description 3
238000006073 displacement reaction Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
238000005194 fractionation Methods 0.000 description 3
239000011521 glass Substances 0.000 description 3
239000012678 infectious agent Substances 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012544 monitoring process Methods 0.000 description 3
238000000465 moulding Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
229920003345 Elvax® Polymers 0.000 description 2
206010018910 Haemolysis Diseases 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
230000001133 acceleration Effects 0.000 description 2
230000004913 activation Effects 0.000 description 2
239000000654 additive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
230000000712 assembly Effects 0.000 description 2
238000000429 assembly Methods 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
238000011109 contamination Methods 0.000 description 2
229920001971 elastomer Polymers 0.000 description 2
238000011049 filling Methods 0.000 description 2
230000005484 gravity Effects 0.000 description 2
230000008588 hemolysis Effects 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
230000010354 integration Effects 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000000203 mixture Substances 0.000 description 2
239000002245 particle Substances 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
238000012360 testing method Methods 0.000 description 2
238000005199 ultracentrifugation Methods 0.000 description 2
208000030507 AIDS Diseases 0.000 description 1
241001662043 Icterus Species 0.000 description 1
206010023126 Jaundice Diseases 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
230000009471 action Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000012491 analyte Substances 0.000 description 1
239000000538 analytical sample Substances 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
238000004159 blood analysis Methods 0.000 description 1
239000012503 blood component Substances 0.000 description 1
229920005557 bromobutyl Polymers 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000035602 clotting Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000001000 lipidemic effect Effects 0.000 description 1
238000011068 loading method Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
238000005192 partition Methods 0.000 description 1
-1 polypropylene Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000010079 rubber tapping Methods 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000009987 spinning Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
239000012815 thermoplastic material Substances 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1

Landscapes

Investigating Or Analysing Biological Materials (AREA)

CA 601973 1989-05-02 1989-06-07 Separateurs pour composants du sang Expired - Fee Related CA1338468C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/346063		1989-05-02
US07/346,063 US5030341A (en)	1987-04-03	1989-05-02	Apparatus for separating phases of blood

Publications (1)

Publication Number	Publication Date
CA1338468C true CA1338468C (fr)	1996-07-23

Family

ID=23357780

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 601973 Expired - Fee Related CA1338468C (fr)	1989-05-02	1989-06-07	Separateurs pour composants du sang

Country Status (1)

Country	Link
CA (1)	CA1338468C (fr)

1989
- 1989-06-07 CA CA 601973 patent/CA1338468C/fr not_active Expired - Fee Related

Legal Events

Date	Code	Title	Description
1999-07-23	MKLA	Lapsed

Publication	Publication Date	Title
US5030341A (en)	1991-07-09	Apparatus for separating phases of blood
US5308506A (en)	1994-05-03	Apparatus and method for separating a sample of blood
EP0341586B1 (fr)	1995-08-23	Appareil pour séparer les phases du sang
US5354483A (en)	1994-10-11	Double-ended tube for separating phases of blood
US5275731A (en)	1994-01-04	Apparatus for rapidly separating blood into filtered fractions
US5271852A (en)	1993-12-21	Centrifugal methods using a phase-separation tube
US5257984A (en)	1993-11-02	Blood collector
US4962044A (en)	1990-10-09	Test tube filter/dispenser apparatus and method
US6153148A (en)	2000-11-28	Centrifugal hematology disposable
US5163582A (en)	1992-11-17	Apparatus and method for aliquotting blood serum or blood plasma
AU606917B2 (en)	1991-02-21	Blood separation system
EP0627261B1 (fr)	1998-05-13	Tube pour la séparation de phases
US5555920A (en)	1996-09-17	Method and apparatus for aliquotting blood serum or blood plasma
US3786985A (en)	1974-01-22	Blood collection container
AU5156193A (en)	1993-11-29	Flow restrictor-separation device
US6132353A (en)	2000-10-17	Apparatus and method for separating plasma or serum from the red cells of a blood sample
WO2017133953A1 (fr)	2017-08-10	Agencement de collecte et de séparation d'un fluide corporel à des fins d'analyse et procédé associé
JP5442699B2 (ja)	2014-03-12	血液サンプルの液状成分を分離する装置および方法、ならびにそのような装置を備える分析装置
EP0245703A2 (fr)	1987-11-19	Dispositif de séparation
WO1994000169A1 (fr)	1994-01-06	Dispositif et systeme de separation du sang
WO2013045695A2 (fr)	2013-04-04	Procédé pour distribuer un échantillon de fluide corporel dans un système d'analyse, seringue conçue pour utilisation dans celui-ci et kit comprenant une telle seringue
CA1338468C (fr)	1996-07-23	Separateurs pour composants du sang
EP4334717B1 (fr)	2025-04-02	Procédé et analyseur d'analyse d'un échantillon de sang
JPH08292190A (ja)	1996-11-05	血液検査容器